New test set to overtake current methods of detection
|
A new test for pancreatic cancer can spot the early signs of the disease
Researchers at Barts, the London NHS Trust and Queen Mary University’s institute of Cancer, have collaborated on a new test, which could help identify victims of pancreatic cancer.
The new testing process, which can reliably detect the presence of cancer in the urine for the first time, has been hailed as a promising step forward in treating people with the condition.
Dr David Tuveson, group leader in tumour modelling and experimental medicine at Cancer UK’s Cambridge Research Institute, said that the test could overtake current methods of detection.
“Some places in the world screen family members where there is a clear family history of the disease, but the major challenge has been to find a reliable way to monitor these people and intervene at the right time. This promising research could give us a new way to do this,” he explained.
| 
Win a pair of coloured contact lenses!
